Molecular mechanism of action of newer thrombolytic agents
- 1 November 1987
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (5) , 11B-15B
- https://doi.org/10.1016/s0735-1097(87)80422-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetics and Thrombolytic Properties of a Nonglycosylated Mutant of Human Tissue-Type Plasminogen Activator, Lacking the Finger and Growth Factor Domains, in Dogs with Copper Coil-Induced Coronary Artery ThrombosisJournal of Cardiovascular Pharmacology, 1988
- Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsAmerican Heart Journal, 1986
- Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- Synergism of thrombolytic agents in vivo.Circulation, 1986
- Comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivityThrombosis Research, 1986
- Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Thrombolysis, clot selectivity, and kinetics.Circulation, 1984